Trial intelligence / Profile preview

Tiotropium Respimat Dose Finding in Asthma

NCT01233284Phase 2Completed

Sponsor
Boehringer Ingelheim
Start
Nov 2010
Primary completion
Jan 2012
Modality
Small Molecules
Countries
3
01

Overview

A Phase 2 trial of tiotropium in asthma, sponsored by Boehringer Ingelheim. Started Nov 2010; status: completed.

02

Drugs

tiotropium
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01233284.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01233284.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call